Tresmonte, Precilda T.
HRN: 20-19-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2022
CEFAZOLIN 1GM (VIAL)
08/28/2022
08/28/2022
IV
2g
SD
S/P NSD NID Retained Placenta
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes